Search
Trastuzumab
go.drugbank.com/drugs/DB00072ApprovedInvestigationalWhile Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer, it is the second biosimilar approved in the U.S. for the treatment of cancer.
Sonidegib
go.drugbank.com/drugs/DB09143ApprovedInvestigationalSonidegib is a Hedgehog signaling pathway inhibitor (via smoothened antagonism) developed as an anticancer agent by Novartis. It was FDA approved in 2015 for the treatment of basal cell carcinoma.
Insulin icodec
go.drugbank.com/drugs/DB16693ApprovedInvestigational[L51078] In July 2024, the US FDA rejected the approval of insulin icodec, citing concerns regarding hypoglycemia and the indication being sought for type 1 diabetes mellitus. … [L51078]The US FDA subsequently approved insulin icodec in March 2026 for use as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. [L56102]
Teriparatide
go.drugbank.com/drugs/DB06285ApprovedInvestigational[A251395] It is made up of the first amino(N)-terminal 34 amino acids of the human PTH.
Adenosine 5'-phosphosulfate
go.drugbank.com/drugs/DB03708InvestigationalSynonyms: adenosine sulfatophosphate; APS.
Synonyms: APSGallium nitrate
go.drugbank.com/drugs/DB05260ApprovedInvestigational[A17097] GANITE, a product of gallium nitrate previously used to treat cancer-related hypercalcemia, was discontinued from marketing in the US for reasons other than safety or effectiveness.
Teduglutide
go.drugbank.com/drugs/DB08900ApprovedInvestigationalIt is made up of 33 amino acids and is manufactured using a strain of Escherichia coli modified by recombinant DNA technology.
Zinc
go.drugbank.com/drugs/DB01593ApprovedInvestigationalA metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficie...
Mixtures: Cps CapsulesLepunafusp alfa
go.drugbank.com/drugs/DB19011InvestigationalLepunafusp alfa is under investigation in clinical trial NCT04453085 (An Extension Study of JR-171-101 Study in Patients With MPS I).